1
|
Dhar A, Gupta SL, Saini P, Sinha K, Khandelwal A, Tyagi R, Singh A, Sharma P, Jaiswal RK. Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2. Immunol Res 2024; 72:14-33. [PMID: 37682455 DOI: 10.1007/s12026-023-09416-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2023] [Accepted: 08/15/2023] [Indexed: 09/09/2023]
Abstract
SARS-CoV-2 (COVID-19) pandemic has been an unpredicted burden on global healthcare system by infecting over 700 million individuals, with approximately 6 million deaths worldwide. COVID-19 significantly impacted all sectors, but it very adversely affected the healthcare system. These effects were much more evident in the resource limited part of the world. Individuals with acute conditions were also severely impacted. Although classical COVID-19 diagnostics such as RT-PCR and rapid antibody testing have played a crucial role in reducing the spread of infection, these diagnostic techniques are associated with certain limitations. For instance, drawback of RT-PCR diagnostics is that due to degradation of viral RNA during shipping, it can give false negative results. Also, rapid antibody testing majorly depends on the phase of infection and cannot be performed on immune compromised individuals. These limitations in current diagnostic tools require the development of nanodiagnostic tools for early detection of COVID-19 infection. Therefore, the SARS-CoV-2 outbreak has necessitated the development of specific, responsive, accurate, rapid, low-cost, and simple-to-use diagnostic tools at point of care. In recent years, early detection has been a challenge for several health diseases that require prompt attention and treatment. Disease identification at an early stage, increased imaging of inner health issues, and ease of diagnostic processes have all been established using a new discipline of laboratory medicine called nanodiagnostics, even before symptoms have appeared. Nanodiagnostics refers to the application of nanoparticles (material with size equal to or less than 100 nm) for medical diagnostic purposes. The special property of nanomaterials compared to their macroscopic counterparts is a lesser signal loss and an enhanced electromagnetic field. Nanosize of the detection material also enhances its sensitivity and increases the signal to noise ratio. Microchips, nanorobots, biosensors, nanoidentification of single-celled structures, and microelectromechanical systems are some of the most modern nanodiagnostics technologies now in development. Here, we have highlighted the important roles of nanotechnology in healthcare sector, with a detailed focus on the management of the COVID-19 pandemic. We outline the different types of nanotechnology-based diagnostic devices for SARS-CoV-2 and the possible applications of nanomaterials in COVID-19 treatment. We also discuss the utility of nanomaterials in formulating preventive strategies against SARS-CoV-2 including their use in manufacture of protective equipment, formulation of vaccines, and strategies for directly hindering viral infection. We further discuss the factors hindering the large-scale accessibility of nanotechnology-based healthcare applications and suggestions for overcoming them.
Collapse
Affiliation(s)
- Atika Dhar
- National Institute of Immunology, New Delhi, India, 110067
| | | | - Pratima Saini
- National Institute of Immunology, New Delhi, India, 110067
| | - Kirti Sinha
- Department of Zoology, Patna Science College, Patna University, Patna, Bihar, India
| | | | - Rohit Tyagi
- College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China
| | - Alka Singh
- Department of Chemistry, Feroze Gandhi College, Raebareli, U.P, India, 229001
| | - Priyanka Sharma
- Department of Zoology, Patna Science College, Patna University, Patna, Bihar, India.
| | - Rishi Kumar Jaiswal
- Department of Cancer Biology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, 60153, USA.
| |
Collapse
|
2
|
Abstract
![]()
Bioactive glasses
(BGs) for biomedical applications are doped with
therapeutic inorganic ions (TIIs) in order to improve their performance
and reduce the side effects related to the surgical implant. Recent
literature in the field shows a rekindled interest toward rare earth
elements, in particular cerium, and their catalytic properties. Cerium-doped
bioactive glasses (Ce-BGs) differ in compositions, synthetic methods,
features, and in vitro assessment. This review provides
an overview on the recent development of Ce-BGs for biomedical applications
and on the evaluation of their bioactivity, cytocompatibility, antibacterial,
antioxidant, and osteogenic and angiogenic properties as a function
of their composition and physicochemical parameters.
Collapse
Affiliation(s)
- Alfonso Zambon
- Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia, via Campi 103, 41125 Modena, Italy
| | - Gianluca Malavasi
- Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia, via Campi 103, 41125 Modena, Italy
| | - Annalisa Pallini
- Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia, via Campi 103, 41125 Modena, Italy
| | - Francesca Fraulini
- Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia, via Campi 103, 41125 Modena, Italy
| | - Gigliola Lusvardi
- Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia, via Campi 103, 41125 Modena, Italy
| |
Collapse
|
3
|
Chung JJ, Yoo J, Sum BST, Li S, Lee S, Kim TH, Li Z, Stevens MM, Georgiou TK, Jung Y, Jones JR. 3D Printed Porous Methacrylate/Silica Hybrid Scaffold for Bone Substitution. Adv Healthc Mater 2021; 10:e2100117. [PMID: 33951318 PMCID: PMC7615494 DOI: 10.1002/adhm.202100117] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2021] [Revised: 03/11/2021] [Indexed: 01/01/2023]
Abstract
Inorganic-organic hybrid biomaterials made with star polymer poly(methyl methacrylate-co-3-(trimethoxysilyl)propyl methacrylate) and silica, which show promising mechanical properties, are 3D printed as bone substitutes for the first time, by direct ink writing of the sol. Three different inorganic:organic ratios of poly(methyl methacrylate-co-3-(trimethoxysilyl)propyl methacrylate)-star-SiO2 hybrid inks are printed with pore channels in the range of 100-200 µm. Mechanical properties of the 3D printed scaffolds fall within the range of trabecular bone, and MC3T3 pre-osteoblast cells are able to adhere to the scaffolds in vitro, regardless of their compositions. Osteogenic and angiogenic properties of the hybrid scaffolds are shown using a rat calvarial defect model. Hybrid scaffolds with 40:60 inorganic:organic composition are able to instigate new vascularized bone formation within its pore channels and polarize macrophages toward M2 phenotype. 3D printing inorganic-organic hybrids with sophisticated polymer structure opens up possibilities to produce novel bone graft materials.
Collapse
Affiliation(s)
- Justin J. Chung
- Department of MaterialsImperial College LondonLondonSW7 2AZUnited Kingdom
- Center for Biomaterials, Biomedical Research InstituteKorea Institute of Science and Technology (KIST)Seoul02792Republic of Korea
| | - Jin Yoo
- Center for Biomaterials, Biomedical Research InstituteKorea Institute of Science and Technology (KIST)Seoul02792Republic of Korea
| | - Brian S. T. Sum
- Department of MaterialsImperial College LondonLondonSW7 2AZUnited Kingdom
| | - Siwei Li
- Department of MaterialsImperial College LondonLondonSW7 2AZUnited Kingdom
| | - Soojin Lee
- Center for Biomaterials, Biomedical Research InstituteKorea Institute of Science and Technology (KIST)Seoul02792Republic of Korea
| | - Tae Hee Kim
- Center for Biomaterials, Biomedical Research InstituteKorea Institute of Science and Technology (KIST)Seoul02792Republic of Korea
| | - Zhenlun Li
- Department of MaterialsImperial College LondonLondonSW7 2AZUnited Kingdom
| | - Molly M. Stevens
- Department of MaterialsImperial College LondonLondonSW7 2AZUnited Kingdom
- Institute of Biomedical EngineeringImperial College LondonLondonSW7 2AZUnited Kingdom
- Department of BioengineeringImperial College LondonLondonSW7 2AZUnited Kingdom
| | - Theoni K. Georgiou
- Department of MaterialsImperial College LondonLondonSW7 2AZUnited Kingdom
| | - Youngmee Jung
- Center for Biomaterials, Biomedical Research InstituteKorea Institute of Science and Technology (KIST)Seoul02792Republic of Korea
- School of Electrical and Electronic EngineeringYonsei UniversitySeoul03722Republic of Korea
- YU‐KIST InstituteYonsei UniversitySeoul03722Republic of Korea
| | - Julian R. Jones
- Department of MaterialsImperial College LondonLondonSW7 2AZUnited Kingdom
| |
Collapse
|
4
|
Fernandes HR, Gaddam A, Rebelo A, Brazete D, Stan GE, Ferreira JMF. Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering. MATERIALS (BASEL, SWITZERLAND) 2018; 11:E2530. [PMID: 30545136 PMCID: PMC6316906 DOI: 10.3390/ma11122530] [Citation(s) in RCA: 98] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/10/2018] [Revised: 12/04/2018] [Accepted: 12/06/2018] [Indexed: 12/12/2022]
Abstract
The discovery of bioactive glasses (BGs) in the late 1960s by Larry Hench et al. was driven by the need for implant materials with an ability to bond to living tissues, which were intended to replace inert metal and plastic implants that were not well tolerated by the body. Among a number of tested compositions, the one that later became designated by the well-known trademark of 45S5 Bioglass® excelled in its ability to bond to bone and soft tissues. Bonding to living tissues was mediated through the formation of an interfacial bone-like hydroxyapatite layer when the bioglass was put in contact with biological fluids in vivo. This feature represented a remarkable milestone, and has inspired many other investigations aiming at further exploring the in vitro and in vivo performances of this and other related BG compositions. This paradigmatic example of a target-oriented research is certainly one of the most valuable contributions that one can learn from Larry Hench. Such a goal-oriented approach needs to be continuously stimulated, aiming at finding out better performing materials to overcome the limitations of the existing ones, including the 45S5 Bioglass®. Its well-known that its main limitations include: (i) the high pH environment that is created by its high sodium content could turn it cytotoxic; (ii) and the poor sintering ability makes the fabrication of porous three-dimensional (3D) scaffolds difficult. All of these relevant features strongly depend on a number of interrelated factors that need to be well compromised. The selected chemical composition strongly determines the glass structure, the biocompatibility, the degradation rate, and the ease of processing (scaffolds fabrication and sintering). This manuscript presents a first general appraisal of the scientific output in the interrelated areas of bioactive glasses and glass-ceramics, scaffolds, implant coatings, and tissue engineering. Then, it gives an overview of the critical issues that need to be considered when developing bioactive glasses for healthcare applications. The aim is to provide knowledge-based tools towards guiding young researchers in the design of new bioactive glass compositions, taking into account the desired functional properties.
Collapse
Affiliation(s)
- Hugo R Fernandes
- Department of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal.
| | - Anuraag Gaddam
- Department of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal.
| | - Avito Rebelo
- Department of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal.
| | - Daniela Brazete
- Department of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal.
| | - George E Stan
- National Institute of Materials Physics, RO-077125 Magurele, Romania.
| | - José M F Ferreira
- Department of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal.
| |
Collapse
|
5
|
|
6
|
Mohan N, Wilson J, Joseph D, Vaikkath D, Nair PD. Biomimetic fiber assembled gradient hydrogel to engineer glycosaminoglycan enriched and mineralized cartilage: Anin vitrostudy. J Biomed Mater Res A 2015; 103:3896-906. [DOI: 10.1002/jbm.a.35506] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2015] [Revised: 05/02/2015] [Accepted: 05/12/2015] [Indexed: 11/06/2022]
Affiliation(s)
- Neethu Mohan
- Division of Tissue Engineering and Regeneration Technologies; Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum Kerala India
| | - Jijo Wilson
- Division of Tissue Engineering and Regeneration Technologies; Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum Kerala India
| | - Dexy Joseph
- Division of Tissue Engineering and Regeneration Technologies; Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum Kerala India
| | - Dhanesh Vaikkath
- Division of Tissue Engineering and Regeneration Technologies; Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum Kerala India
| | - Prabha D. Nair
- Division of Tissue Engineering and Regeneration Technologies; Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum Kerala India
| |
Collapse
|
7
|
Izquierdo-Barba I, Vallet-Regí M. Mesoporous bioactive glasses: Relevance of their porous structure compared to that of classical bioglasses. BIOMEDICAL GLASSES 2015. [DOI: 10.1515/bglass-2015-0014] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
AbstractIn the last decade, the development of third generation bioceramics for Bone Tissue Regeneration has experienced significant progress with the emergence of a new generation of nanostructured materials named mesoporous bioactive glasses (MBG). This new generation of materials, also known as “templated glasses”, presents chemical compositions similar to those of conventional bioactive sol–gel glasses and the added value of an ordered mesopore arrangement. This article shows an indepth comparative study of the ordered porous structures of MBGs compared to conventional glasses (melt and solgel) andhowthese properties influence the bioactivity process. Moreover, the possibility to tailor the textural and structural properties of these nanostructured materials by an exhaustive control of the different synthesis parameters is also discussed. A brief overview regarding the possibility of using these materials as controlled drug delivery systems and as starting materials for the fabrication of 3D scaffolds for bone tissue regeneration is also given.
Collapse
|
8
|
Henstock JR, Canham LT, Anderson SI. Silicon: the evolution of its use in biomaterials. Acta Biomater 2015; 11:17-26. [PMID: 25246311 DOI: 10.1016/j.actbio.2014.09.025] [Citation(s) in RCA: 98] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2014] [Revised: 08/26/2014] [Accepted: 09/15/2014] [Indexed: 11/18/2022]
Abstract
In the 1970s, several studies revealed the requirement for silicon in bone development, while bioactive silicate glasses simultaneously pioneered the current era of bioactive materials. Considerable research has subsequently focused on the chemistry and biological function of silicon in bone, demonstrating that the element has at least two separate effects in the extracellular matrix: (i) interacting with glycosaminoglycans and proteoglycans during their synthesis, and (ii) forming ionic substitutions in the crystal lattice structure of hydroxyapatite. In addition, the dissolution products of bioactive glass (predominantly silicic acids) have significant effects on the molecular biology of osteoblasts in vitro, regulating the expression of several genes including key osteoblastic markers, cell cycle regulators and extracellular matrix proteins. Researchers have sought to capitalize on these effects and have generated a diverse array of biomaterials, which include bioactive glasses, silicon-substituted hydroxyapatites and pure, porosified silicon, but all these materials share similarities in the mechanisms that result in their bioactivity. This review discusses the current data obtained from original research in biochemistry and biomaterials science supporting the role of silicon in bone, comparing both the biological function of the element and analysing the evolution of silicon-containing biomaterials.
Collapse
Affiliation(s)
- J R Henstock
- Institute for Science and Technology in Medicine, Keele University, Stoke-on-Trent ST4 7QB, UK.
| | - L T Canham
- pSiMedica Ltd, Malvern Hills Science Park, Malvern, Worcestershire WR14 3SZ, UK
| | - S I Anderson
- University of Nottingham School of Medicine, Division of Medical Science and Graduate Entry Medicine, Royal Derby Hospital Centre, Uttoxeter Road, Derby DE22 3DT, UK
| |
Collapse
|
9
|
Qian M, Liu M, Duan M, Wu Z, Zhou Y. Synthesis of Composites SBA-15 Mesoporous Particles Carrying Oxytocin and Evaluation of Their Properties, Functions, and In Vitro Biological Activities. Cell Biochem Biophys 2014; 71:127-34. [DOI: 10.1007/s12013-014-0172-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
10
|
Brie IC, Soritau O, Dirzu N, Berce C, Vulpoi A, Popa C, Todea M, Simon S, Perde-Schrepler M, Virag P, Barbos O, Chereches G, Berce P, Cernea V. Comparative in vitro study regarding the biocompatibility of titanium-base composites infiltrated with hydroxyapatite or silicatitanate. J Biol Eng 2014; 8:14. [PMID: 24987458 PMCID: PMC4077223 DOI: 10.1186/1754-1611-8-14] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2013] [Accepted: 06/13/2014] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND The development of novel biomaterials able to control cell activities and direct their fate is warranted for engineering functional bone tissues. Adding bioactive materials can improve new bone formation and better osseointegration. Three types of titanium (Ti) implants were tested for in vitro biocompatibility in this comparative study: Ti6Al7Nb implants with 25% total porosity used as controls, implants infiltrated using a sol-gel method with hydroxyapatite (Ti HA) and silicatitanate (Ti SiO2). The behavior of human osteoblasts was observed in terms of adhesion, cell growth and differentiation. RESULTS The two coating methods have provided different morphological and chemical properties (SEM and EDX analysis). Cell attachment in the first hour was slower on the Ti HA scaffolds when compared to Ti SiO2 and porous uncoated Ti implants. The Alamar blue test and the assessment of total protein content uncovered a peak of metabolic activity at day 8-9 with an advantage for Ti SiO2 implants. Osteoblast differentiation and de novo mineralization, evaluated by osteopontin (OP) expression (ELISA and immnocytochemistry), alkaline phosphatase (ALP) activity, calcium deposition (alizarin red), collagen synthesis (SIRCOL test and immnocytochemical staining) and osteocalcin (OC) expression, highlighted the higher osteoconductive ability of Ti HA implants. Higher soluble collagen levels were found for cells cultured in simple osteogenic differentiation medium on control Ti and Ti SiO2 implants. Osteocalcin (OC), a marker of terminal osteoblastic differentiation, was most strongly expressed in osteoblasts cultivated on Ti SiO2 implants. CONCLUSIONS The behavior of osteoblasts depends on the type of implant and culture conditions. Ti SiO2 scaffolds sustain osteoblast adhesion and promote differentiation with increased collagen and non-collagenic proteins (OP and OC) production. Ti HA implants have a lower ability to induce cell adhesion and proliferation but an increased capacity to induce early mineralization. Addition of growth factors BMP-2 and TGFβ1 in differentiation medium did not improve the mineralization process. Both types of infiltrates have their advantages and limitations, which can be exploited depending on local conditions of bone lesions that have to be repaired. These limitations can also be offset through methods of functionalization with biomolecules involved in osteogenesis.
Collapse
Affiliation(s)
- Ioana-Carmen Brie
- The Institute of Oncology "Prof. Dr. I. Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania ; University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca, Cluj-Napoca, Romania
| | - Olga Soritau
- The Institute of Oncology "Prof. Dr. I. Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania
| | | | - Cristian Berce
- University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca, Cluj-Napoca, Romania
| | - Adriana Vulpoi
- Faculty of Physics & Institute of Interdisciplinary Research in Bio-Nano-Sciences, Babes Bolyai University, 400084 Cluj-Napoca, Romania
| | | | - Milica Todea
- Faculty of Physics & Institute of Interdisciplinary Research in Bio-Nano-Sciences, Babes Bolyai University, 400084 Cluj-Napoca, Romania
| | - Simion Simon
- Faculty of Physics & Institute of Interdisciplinary Research in Bio-Nano-Sciences, Babes Bolyai University, 400084 Cluj-Napoca, Romania
| | - Maria Perde-Schrepler
- The Institute of Oncology "Prof. Dr. I. Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania
| | - Piroska Virag
- The Institute of Oncology "Prof. Dr. I. Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania
| | - Otilia Barbos
- The Institute of Oncology "Prof. Dr. I. Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania
| | - Gabriela Chereches
- The Institute of Oncology "Prof. Dr. I. Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania
| | | | - Valentin Cernea
- The Institute of Oncology "Prof. Dr. I. Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania ; University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca, Cluj-Napoca, Romania
| |
Collapse
|
11
|
Alharbi KK, Al-sheikh YA. Role and implications of nanodiagnostics in the changing trends of clinical diagnosis. Saudi J Biol Sci 2014; 21:109-17. [PMID: 24600302 PMCID: PMC3942856 DOI: 10.1016/j.sjbs.2013.11.001] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2013] [Revised: 11/03/2013] [Accepted: 11/03/2013] [Indexed: 11/18/2022] Open
Abstract
Nanodiagnostics is the term used for the application of nanobiotechnology in molecular diagnosis, which is important for developing personalized cancer therapy. It is usually based on pharmacogenetics, pharmacogenomics, and pharmacoproteomic information but also takes into consideration environmental factors that influence response to therapy. Nanotechnology in medicine involves applications of nanoparticles currently under development, as well as longer range research that involves the use of manufactured nano-robots to make repairs at the cellular level. Nanodiagnostic technologies are also being used to refine the discovery of biomarkers, as nanoparticles offer advantages of high volume/surface ratio and multifunctionality. Biomarkers are important basic components of personalized medicine and are applicable to the management of cancer as well. The field of nano diagnostics raises certain ethical concerns related with the testing of blood. With advances in diagnostic technologies, doctors will be able to give patients complete health checks quickly and routinely. If any medication is required this will be tailored specifically to the individual based on their genetic makeup, thus preventing unwanted side-effects.
Collapse
Affiliation(s)
- Khalid Khalaf Alharbi
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia
| | | |
Collapse
|
12
|
Goff T, Kanakaris NK, Giannoudis PV. Use of bone graft substitutes in the management of tibial plateau fractures. Injury 2013; 44 Suppl 1:S86-94. [PMID: 23351879 DOI: 10.1016/s0020-1383(13)70019-6] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The current available evidence for the use of bone graft substitutes in the management of subchondral bone defects associated with tibial plateau fractures as to their efficiency and safety has been collected following a literature review of the Ovid MEDLINE (1948-Present) and EMBASE (1980-Present). Nineteen studies were analysed reporting on 672 patients (674 fractures), with a mean age of 50.35 years (range 15-89), and a gender ratio of 3/2 males/females. The graft substitutes evaluated in the included studies were calcium phosphate cement, hydroxyapatite granules, calcium sulphate, bioactive glass, tricalcium phosphate, demineralised bone matrix, allografts, and xenograft. Fracture healing was uneventful in over 90% of the cases over a variant period of time. Besides two studies reporting on injectable calcium phosphate cement excellent incorporation was reported within 6 to 36 months post-surgery. No correlation was made by any of the authors between poor incorporation/resorption and adverse functional or radiological outcome. Secondary collapse of the knee joint surface ≥ 2 mm was reported in 8.6% in the biological substitutes (allograft, DBM, and xenograft), 5.4% in the hydroxyapatite, 3.7% in the calcium phosphate cement, and 11.1% in the calcium sulphate cases. The recorded incidence of primary surgical site and donor site infection (3.6%) was not statistically significant different, however donor site-related pain was reported up to 12 months following autologous iliac bone graft (AIBG) harvest. Shorter total operative time, greater tolerance of early weight bearing, improved early functional outcomes within the first year post-surgery was also recorded in the studies reporting on the use of injectable calcium phosphate cement (Norian SRS). Despite a lack of good quality randomised control trials, there is arguably sufficient evidence supporting the use of bone graft substitutes at the clinical setting of depressed plateau fractures.
Collapse
Affiliation(s)
- Thomas Goff
- Academic Department of Trauma and Orthopaedics, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | | | | |
Collapse
|
13
|
Alves Cardoso D, Jansen JA, Leeuwenburgh SCG. Synthesis and application of nanostructured calcium phosphate ceramics for bone regeneration. J Biomed Mater Res B Appl Biomater 2012; 100:2316-26. [PMID: 23015272 DOI: 10.1002/jbm.b.32794] [Citation(s) in RCA: 71] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2012] [Revised: 07/13/2012] [Accepted: 07/14/2012] [Indexed: 01/02/2023]
Abstract
In the past two decades, nanotechnology has entered the field of regenerative medicine, resulting in the development of a novel generation of instructive, nanostructured biomaterials that are able to orchestrate cellular behavior by presenting specific morphological and biological cues. Using nanotechnology, materials containing nanosized features (e.g., pores, patterns, textures, grain sizes) can be obtained that exhibit properties that are considerably altered compared with micron-structured materials. Inspired by the hierarchical nanostructure of bone, the application of nanostructured materials for bone regeneration is gaining increasing interest in the field of biomaterials research. Because crystallographic and chemical studies have shown that synthetic hydroxyapatite closely resembles the inorganic phase found in bone and teeth, synthesis and applications of nanostructured calcium phosphate ceramics have been reviewed. Synthesis techniques for the preparation of calcium phosphate nanoparticles include precipitation, sol-gel, and hydrothermal processes, whereas four main biomedical applications of nanostructured calcium phosphate ceramics in bone regeneration have been addressed in more detail, that is, (1) polymer/calcium phosphate nanocomposites, (2) nanostructured monophasic calcium phosphate bone fillers, (3) nanostructured precursor phases for calcium phosphate cements, and (4) nanostructured calcium phosphate coatings.
Collapse
Affiliation(s)
- D Alves Cardoso
- Department of Biomaterials, Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands
| | | | | |
Collapse
|
14
|
Hu G, Xiao L, Tong P, Bi D, Wang H, Ma H, Zhu G, Liu H. Antibacterial hemostatic dressings with nanoporous bioglass containing silver. Int J Nanomedicine 2012; 7:2613-20. [PMID: 22745538 PMCID: PMC3383339 DOI: 10.2147/ijn.s31081] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Nanoporous bioglass containing silver (n-BGS) was fabricated using the sol-gel method, with cetyltrimethyl ammonium bromide as template. The results showed that n-BGS with nanoporous structure had a surface area of 467 m2/g and a pore size of around 6 nm, and exhibited a significantly higher water absorption rate compared with BGS without nanopores. The n-BGS containing small amounts of silver (Ag) had a slight effect on its surface area. The n-BGS containing 0.02 wt% Ag, without cytotoxicity, had a good antibacterial effect on Escherichia coli, and its antibacterial rate reached 99% in 12 hours. The n-BGS’s clotting ability significantly decreased prothrombin time (PT) and activated partial thromboplastin time (APTT), indicating n-BGS with a higher surface area could significantly promote blood clotting (by decreasing clotting time) compared with BGS without nanopores. Effective hemostasis was achieved in skin injury models, and bleeding time was reduced. It is suggested that n-BGS could be a good dressing, with antibacterial and hemostatic properties, which might shorten wound bleeding time and control hemorrhage.
Collapse
Affiliation(s)
- Gangfeng Hu
- The First People's Hospital of Xiaoshan, Hangzhou, China.
| | | | | | | | | | | | | | | |
Collapse
|
15
|
Valliant EM, Turdean-Ionescu CA, Hanna JV, Smith ME, Jones JR. Role of pH and temperature on silica network formation and calcium incorporation into sol–gel derived bioactive glasses. ACTA ACUST UNITED AC 2012. [DOI: 10.1039/c1jm13225c] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
16
|
Janicki P, Schmidmaier G. What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury 2011; 42 Suppl 2:S77-81. [PMID: 21724186 DOI: 10.1016/j.injury.2011.06.014] [Citation(s) in RCA: 165] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Reconstruction of large bone defects or non-unions resulting from biochemical disorders, tumour resections or complicated fractures is still a challenge for orthopaedic and trauma surgery. On the one hand, autografts harbour most features of ideal bone graft substitutes but on the other hand, they have a lot insurmountable disadvantages. An ideal bone graft substitute should be biomechanically stable, able to degrade within an appropriate time frame, exhibit osteoconductive, osteogenic and osteoinductive properties and provide a favourable environment for invading blood vessels and bone forming cells. Whilst osteoconductivity of biomaterials for bone tissue engineering strategies can be directed by their composition, surface character and internal structure, osteoinductive and osteogenic features can be provided by growth factors originally participating in fracture healing and/or multipotent mesenchymal stromal/stem cells (MSC) capable of rebuilding bone and marrow structures. In this review, aspects of the clinical application of the most commonly used growth factors for bone repair, the bone morphogenetic proteins (BMPs), and the potential use of human MSC for clinical application will be discussed.
Collapse
Affiliation(s)
- Patricia Janicki
- Research Center for Experimental Orthopedics, Department of Orthopedics, Trauma Surgery and Paraplegiology, Heidelberg University Hospital, Heidelberg, Germany
| | | |
Collapse
|
17
|
Degradation, bioactivity, and osteogenic potential of composites made of PLGA and two different sol-gel bioactive glasses. Ann Biomed Eng 2011; 39:2114-29. [PMID: 21487840 PMCID: PMC3127015 DOI: 10.1007/s10439-011-0307-4] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2010] [Accepted: 03/28/2011] [Indexed: 11/08/2022]
Abstract
We have developed poly(l-lactide-co-glycolide) (PLGA) based composites using sol–gel derived bioactive glasses (S-BG), previously described by our group, as composite components. Two different composite types were manufactured that contained either S2—high content silica S-BG, or A2—high content lime S-BG. The composites were evaluated in the form of sheets and 3D scaffolds. Sheets containing 12, 21, and 33 vol.% of each bioactive glass were characterized for mechanical properties, wettability, hydrolytic degradation, and surface bioactivity. Sheets containing A2 S-BG rapidly formed a hydroxyapatite surface layer after incubation in simulated body fluid. The incorporation of either S-BG increased the tensile strength and Young’s modulus of the composites and tailored their degradation rates compared to starting compounds. Sheets and 3D scaffolds were evaluated for their ability to support growth of human bone marrow cells (BMC) and MG-63 cells, respectively. Cells were grown in non-differentiating, osteogenic or osteoclast-inducing conditions. Osteogenesis was induced with either recombinant human BMP-2 or dexamethasone, and osteoclast formation with M-CSF. BMC viability was lower at higher S-BG content, though specific ALP/cell was significantly higher on PLGA/A2-33 composites. Composites containing S2 S-BG enhanced calcification of extracellular matrix by BMC, whereas incorporation of A2 S-BG in the composites promoted osteoclast formation from BMC. MG-63 osteoblast-like cells seeded in porous scaffolds containing S2 maintained viability and secreted collagen and calcium throughout the scaffolds. Overall, the presented data show functional versatility of the composites studied and indicate their potential to design a wide variety of implant materials differing in physico-chemical properties and biological applications. We propose these sol–gel derived bioactive glass–PLGA composites may prove excellent potential orthopedic and dental biomaterials supporting bone formation and remodeling.
Collapse
|
18
|
Aina V, Ghigo D, Marchis T, Cerrato G, Laurenti E, Morterra C, Malavasi G, Lusvardi G, Menabue L, Bergandi L. Novel bio-conjugate materials: soybean peroxidase immobilized on bioactive glasses containing Au nanoparticles. ACTA ACUST UNITED AC 2011. [DOI: 10.1039/c1jm10442j] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
19
|
Jones JR, Lin S, Yue S, Lee PD, Hanna JV, Smith ME, Newport RJ. Bioactive glass scaffolds for bone regeneration and their hierarchical characterisation. Proc Inst Mech Eng H 2010; 224:1373-87. [DOI: 10.1243/09544119jeim836] [Citation(s) in RCA: 89] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Scaffolds are needed that can act as temporary templates for bone regeneration and actively stimulate vascularized bone growth so that bone grafting is no longer necessary. To achieve this, the scaffold must have a suitable interconnected pore network and be made of an osteogenic material. Bioactive glass is an ideal material because it rapidly bonds to bone and degrades over time, releasing soluble silica and calcium ions that are thought to stimulate osteoprogenitor cells. Melt-derived bioactive glasses, such as the original Bioglass® composition, are available commercially, but porous scaffolds have been difficult to produce because Bioglass and similar compositions crystallize on sintering. Sol-gel foam scaffolds have been developed that avoid this problem. They have a hierarchical pore structure comprising interconnected macropores, with interconnect diameters in excess of the 100 μm that is thought to be needed for vascularized bone ingrowth, and an inherent nanoporosity of interconnected mesopores (2–50 nm) which is beneficial for the attachment of osteoprogenitor cells. They also have a compressive strength in the range of cancellous bone. This paper describes the optimized sol-gel foaming process and illustrates the importance of optimizing the hierarchical structure from the atomic through nano, to the macro scale with respect to biological response.
Collapse
Affiliation(s)
- J R Jones
- Department of Materials, Imperial College London, South Kensington Campus, London, UK
| | - S Lin
- Department of Materials, Imperial College London, South Kensington Campus, London, UK
| | - S Yue
- Department of Materials, Imperial College London, South Kensington Campus, London, UK
| | - P D Lee
- Department of Materials, Imperial College London, South Kensington Campus, London, UK
| | - J V Hanna
- Department of Physics, University of Warwick, Coventry, UK
| | - M E Smith
- Department of Physics, University of Warwick, Coventry, UK
| | - R J Newport
- School of Physical Sciences, Ingram Building, University of Kent, Canterbury, UK
| |
Collapse
|
20
|
Abstract
Mesoporous materials synthesized using a polymer templating route have attracted considerable attention in the field of bone tissue regeneration because their unique pore textural properties (high specific surface area, pore volume and controllable mesopore structure) can promote rapid bone formation. In addition, their potential use as a drug delivery system has been highlighted. The scaffolds in bone tissue regeneration should contain 3D interconnected pores ranging in size from 10 to 1000 μm for successful cell migration, nutrient delivery, bone in-growth and vascularization. Meso-sized pores are too small to carry out these roles, even though mesoporous materials have attractive functionalities for bone tissue regeneration. Therefore, a technique linking mesoporous materials with the general scaffolds is required. This paper reviews recent studies relating the development of new porous scaffolds containing mesopores for using in bone tissue regeneration. All the suggested methods, such as a combination of polymer templating methods and rapid prototyping technique can provide hierarchically 3D porous bioactive scaffolds with well interconnected pore structures in the nano to macro size range, good molding capability, biocompatibility, and bioactivity. The new fabrication techniques suggested can potentially be used to design ideal scaffolds in bone tissue regeneration.
Collapse
|
21
|
Poologasundarampillai G, Ionescu C, Tsigkou O, Murugesan M, Hill RG, Stevens MM, Hanna JV, Smith ME, Jones JR. Synthesis of bioactive class II poly(γ-glutamic acid)/silica hybrids for bone regeneration. ACTA ACUST UNITED AC 2010. [DOI: 10.1039/c0jm00930j] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|